# Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases

> **NCT01417403** · PHASE1 · TERMINATED · sponsor: **Virginia Commonwealth University** · enrollment: 10 (actual)

## Conditions studied

- Bone Metastases
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** hydroxychloroquine
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT01417403
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-08
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Recently published data that has shown HCQ to be safe when combined with chemo and or radiation at even higher doses than what is used in this study.
- **Last updated:** 2015-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01417403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01417403, "Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01417403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*